drugset
drugset / Trial / NCT01156012

Efficacy and Safety Assessment of T2345 in Ocular Hypertensive or Glaucomatous Patients

NCT01156012 ↗

Phase 3 Completed 404 enrolled Laboratoires Thea
RandomizedParallel-groupSingle-blindTreatment

Summary

The purpose of this study is to assess the efficacy and safety of T2345 versus active comparator.

Timeline

Start
2009-09
Primary completion
2010-12
Completion
2010-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Latanoprost Small molecule — —

Indications

glaucoma